Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 12, Issue 5, 2010, Pages 339-345

  Conway, Baqiyyah ^a   Edmundowicz, Daniel ^b   Matter, Nathaniel ^c   Maynard, John ^c   Orchard, Trevor ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c VeraLight   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN;

ADULT; AGE DISTRIBUTION; ARTERY CALCIFICATION; ARTICLE; CORONARY ARTERY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKIN INTRINSIC FLUORESCENCE;

ADULT; CALCINOSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SKIN; SPECTROMETRY, FLUORESCENCE;

EID: 77951145122     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0152     Document Type: Article

References (36)

1. Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M; Coronary Artery Calcification in Type 1 Diabetes Study: Effect of type 1 diabetes on the gender difference in coronary artery calcificaion: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes 2003;52:2833-2839.
2. Rumberger JA, Brundage BH, Rader DJ, Kondos G: Electronbeam tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999;74:243-252.
3. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ: Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 2000;49:1571-1578.
4. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD: Prediction of coronary events with electron-beam tomography. J Am Coll Cardiol 2000;36:1253-1260.
5. Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, Zelinger A, Mahmarian JJ: Identification of patients at increased risk of unheralded myocardial infarction by electronbeam computed tomography. Circulation 2000;101:850-855.
6. Rumberger JA, Sheedy PF 3rd, Breen JF, Schwartz RS: Coronary calcium, as determined by electron beam computed tomography, and coronary disease on arteriogram. Circulation 1995;91:1363-1367.
7. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA: Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336-1345.
8. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA, Fuh H, Manogue KR, Cermai A, Vlassara H: Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 1994;343:1519-1522.
9. Dawnay A, Millar DJ: The pathogenesis and consequenves of AGE formation in uraemia and its treatment. Cell Mol Biol (Noisy-le-grand) 1998;44:1081-1094.
10. Verzijl N, DeGroot J, Thorpe SR, Bank TA, Shaw JN, Lyons TJ, Bijlsma JW, Lafeber FP, Baynes JW, TeKoppele JM: Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000;50:39027-39031.
11. Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H: Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun 1999;258:353-357.
12. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S: Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 1999;48:870-880.
13. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330.
14. Conway B, Wang J, Ediger W, Orchard T: Skin fluorescence and type 1 diabetes: a new marker of complication risk [abstract]. Diabetes 2008;57(Suppl 11):A287.
15. Taki K, Takayama F, Tsuruta Y, Niwa T: Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 2006;70:218-224.
16. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycation end products in patients with diabetic nephropathy. N Engl J Med 1991;325:836-842.
17. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis J, LaPorte RE, Kuller LH: The prevalence of complications in insulin-dependent diabetes mellitus by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990;39:1116-1124.
18. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Ellis J, LaPorte RE, Kuller LH, Wolfson SK Jr, Drash AL: Factors associated with the avoidance of severe complications after 25 yr of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 1990;13:741-747.
19. Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P: Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998;208:807-814.
20. Warnick GR, Albers JJ: Heparin-Mn2+ quantitation of highdensity- lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin Chem 1978;24:900-904.
21. National Institutes of Health: Lipid Research Clinics Program. NIH publication number 75-628. Washington, DC: U.S. Government Printing Office, 1975.
22. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
23. Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN: Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1c. Diabetes Care 2007;30:1120-1124.
24. Ediger MN, Olson BP, Maynard JD: Noninvasive optical screening for diabetes. J Diabetes Sci Technol 2009;4:776-780.
25. Hull E, Ediger M, Unione A, Deemer E, Stroman M, Baynes J: Noninvasive, optical detection of diabetes: model studies with porcine skin. Opt Express 2004;12:4496-4510.
26. Hokanson JE, MacKenzie T, Kinney G, Snell-Bergeon JK, Dabelea D, Ehrlich J, Eckel RH, Rewers M: Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AM J Roentgenol 2004;182:1327-1332.
27. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp- Sijders C, Bouter LM, Heine RJ: Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996;39:298-305.
28. Sakata N, Takeuchi K, Noda K, Keijrp S, Tachikawa Y, Tashiro T, Nagai R, Horiuchi S: Calcification of the medial layer of the internal thoracic artery in diabetic patients: relevance of glycoxidation. J Vasc Res 2003;40:467-574.
29. Edmonds ME, Morrison N, Laws JW, Watkins PJ: Medial arterial calcification and diabetic neuropathy. Br Med J (Clin Res Ed) 1982;284:928-930.
30. Goebel FD, Fü essl HS: Mö ckenberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia 1983;24:347-350.
31. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, Edmundowicz D, Orchard TJ: Double-edged relationship between adiposity and coronary artery calcification in type 1 diabetes. Diab Vasc Dis Res 2007;4:332-339.
32. Costacou T, Huskey ND, Edmundowicz D, Stolk R, Orchard TJ: Lower-extremity arterial calcification as a correlate of coronary artery calcification. Metabolism 2006;55:1689-1696.
33. Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group: Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study. Diabetologia 2009;52:705-714.
34. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ: Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009; 52:789-797.
35. Yamagishi S, Nakamura K, Imaizumi T: Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev 2005;1:93-106.
36. Niskanen L, Sitonen O, Suhonen M, Uusitupa M: Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care 1994;17:1252-1756.